Targeted prophylaxis
Showing 1 - 25 of 8,170
Cancer Therapy-Related Diarrhea, Chemo-related Diarrhea, Adult Solid Tumor Trial in United States (Crofelemer 125 MG [Mytesi],
Recruiting
- Cancer Therapy-Related Diarrhea
- +5 more
- Crofelemer 125 MG [Mytesi]
- Placebo
-
Corona, California
- +13 more
May 2, 2022
Infection Trial in United States (Transperineal MRI-guided prostate biopsy, Transrectal MRI-guided prostate biopsy, Antibiotic
Recruiting
- Infection
- Transperineal MRI-guided prostate biopsy
- +2 more
-
Farmington, Connecticut
- +10 more
Aug 30, 2022
Kidney Transplant Infection Trial in Bordeaux, Lyon (Group 1_No proph treatment, Group 2A_Proph treatment and ?d T cell
Completed
- Kidney Transplant Infection
- Group 1_No proph treatment
- +2 more
-
Bordeaux, France
- +1 more
Jun 4, 2021
Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia Trial in New York (Fludarabine, Busulfan,
Completed
- Acute Myelogenous Leukemia
- +2 more
- Fludarabine
- +5 more
-
New York, New YorkColumbia University Medical Center
Aug 4, 2021
HIV Prevention Trial in Los Angeles, San Diego (Text Messaging, Adherence Counseling, Daily Oral PrEP)
Completed
- HIV Prevention
- Text Messaging
- +2 more
-
Los Angeles, California
- +4 more
Jun 15, 2021
Acute Leukemia, MDS Trial in Chicago (device, drug, other)
Recruiting
- Acute Leukemia
- MDS
- Arm1
- Arm 1
-
Chicago, IllinoisUniversity of Illinois Cancer Center
Oct 13, 2022
Infection Trial in Chicago, Baltimore, New York (Transperineal MRI-guided prostate biopsy, Transrectal MRI-guided prostate
Recruiting
- Infection
- Transperineal MRI-guided prostate biopsy
- +2 more
-
Chicago, Illinois
- +3 more
Nov 1, 2022
Liver Transplant Recipients Colonized With Carbapenem Resistant
Not yet recruiting
- Liver Transplantation
- Carbapenem-Resistant Enterobacteriaceae Colonization
- Application of a prognostic score
-
São Paulo, Brazil
- +5 more
Oct 21, 2022
HIV, Pregnancy Related Trial in Kenya (Universal PrEP Counseling, Targeted PrEP Counseling)
Completed
- HIV Infections
- Pregnancy Related
- Universal PrEP Counseling
- Targeted PrEP Counseling
-
Ambira, Kenya
- +19 more
Jul 11, 2022
Overactive Bladder, Overactive Bladder Syndrome, Urge Incontinence Trial in Cleveland (Single-Dose Antibiotic, Multi-Dose
Enrolling by invitation
- Overactive Bladder
- +3 more
- Single-Dose Antibiotic
- Multi-Dose Antibiotic
-
Cleveland, OhioCleveland Clinic Foundation
Jan 31, 2023
Surgical Site Infection, Microbial Colonization, Antibiotic Resistant Infection Trial (Standard antibiotic prophylaxis)
Not yet recruiting
- Surgical Site Infection
- +2 more
- Standard antibiotic prophylaxis
- (no location specified)
Aug 12, 2022
Acceptability ofPrEP Program Among MSM and Transgender and
Not yet recruiting
- HIV Infections
- STI
- acceptability of a PrEP program among HIV-negative MSM and TG
- (no location specified)
Jul 10, 2023
Urinary Tract Infections, Stent Related Infection Trial in Gent (Double-J stent removal)
Recruiting
- Urinary Tract Infections
- Stent Related Infection
- Double-J stent removal
-
Gent, Eastern-Flanders, BelgiumUniversity Hospital Ghent
Dec 19, 2022
Leprosy Trial in Moroni (BE-PEP Bedaquiline, SDR-PEP Rifampicin, BE-PEP Rifampicin)
Not yet recruiting
- Leprosy
- BE-PEP Bedaquiline
- +2 more
-
Moroni, ComorosFondation Damien
Oct 24, 2022
Leukemia, Non-Hodgkins Lymphoma, Hodgkins Lymphoma Trial run by the NCI (EPOCH-F/R, FLAG, Transplant Preparative Regimen
Terminated
- Leukemia
- +4 more
- EPOCH-F/R
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)
Active, not recruiting
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Gemtuzumab Ozogamicin
-
Valhalla, New YorkNew York Medical College
Sep 26, 2022
HIV, Insulin Sensitivity, Diabetes Trial in Gaborone (Zidovudine, Nevirapine)
Completed
- HIV
- +2 more
-
Gaborone, BotswanaBotswana-Harvard AIDS Institute Partnership
Jul 18, 2022
Pre-exposure Prophylaxis, HIV Trial in Cape Town (Social Media Campaign, PrEP Champions, Community Mobilization)
Recruiting
- Pre-exposure Prophylaxis
- HIV Infections
- Social Media Campaign
- +2 more
-
Cape Town, Western Cape, South AfricaTB HIV Care
Oct 24, 2022
Utilization, Health Care, Birth Outcomes Trial in Kano (Conditional cash transfer, Risk information provision)
Active, not recruiting
- Utilization, Health Care
- Birth Outcomes
- Conditional cash transfer
- Risk information provision
-
Kano, NigeriaAminu Kano Teaching Hospital
Oct 19, 2022
Prostate Biopsy, Antibiotic Trial in Berlin, Oslo (Transperineal prostate biopsy with or without antibiotic prophylaxis)
Completed
- Prostate Biopsy
- Antibiotic
- Transperineal prostate biopsy with or without antibiotic prophylaxis
-
Berlin, Germany
- +1 more
Dec 4, 2021
HIV, Tuberculosis, Hypertension Trial in Nyanza Province, Mbale/Tororo Region, Mbarara Region (Universal ART in a streamlined
Completed
- HIV
- +5 more
- Universal ART in a streamlined care model
- +3 more
-
Nyanza Province, Kenya
- +2 more
Feb 7, 2022
Coronary Artery Disease, Aortic Valve Disease Trial in Copenhagen (Tocilizumab, Isotonic sodium chloride (0.9%), Dexamethasone
Recruiting
- Coronary Artery Disease
- Aortic Valve Disease
- Tocilizumab
- +8 more
-
Copenhagen, DenmarkThe Heart Centre, Rigshospitalet
Nov 29, 2022
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Frankfurt (Main) (Rituximab, Nelarabine, PEG-Asparaginase)
Recruiting
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Rituximab
- +18 more
-
Frankfurt (Main), GermanyUniversity Hospital of Frankfurt (Main)
Jul 1, 2022